Sandoz announces exclusive deal to commercialize biosimilar ustekinumab, further reinforcing growing pipeline and immunology patient offering

Related Stories

Cregis Shines at Paris Blockchain Week 2026, Accelerating European Expansion

SeoulCeuticals Publishes First Official Layering Guide for Volufiline Snail Mucin Serum, Identifying Retinol Sequencing as the Cause of Preventable Irritation for Millions of Users

Verum Messenger Introduces Major Platform Update Expanding Privacy, Connectivity, and Digital Ecosystem

Studio 6 Grows Extended Stay Footprint with 35+ New Locations in 2026

Kaltura to Showcase Agentic Revenue Engagement Platform at Adobe Summit 2026, Demonstrating How Agentic AI Avatars and Content Intelligence Turn Static ABM Pages Into Real-Time Conversations

OSS Plans to Showcase Specialized High-Performance AI Computing Solutions at The Navy League’s Sea-Air-Space Exposition on April 19-22

You may have missed

Cregis Shines at Paris Blockchain Week 2026, Accelerating European Expansion

SeoulCeuticals Publishes First Official Layering Guide for Volufiline Snail Mucin Serum, Identifying Retinol Sequencing as the Cause of Preventable Irritation for Millions of Users

Verum Messenger Introduces Major Platform Update Expanding Privacy, Connectivity, and Digital Ecosystem

Studio 6 Grows Extended Stay Footprint with 35+ New Locations in 2026

Kaltura to Showcase Agentic Revenue Engagement Platform at Adobe Summit 2026, Demonstrating How Agentic AI Avatars and Content Intelligence Turn Static ABM Pages Into Real-Time Conversations

error: Content is protected !!